Skip to main content

Advertisement

Table 1 Clinical and hematological features of MDS patients

From: Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors

N° of patients 54
Sex (male/female) 34/20
Age, median years (range) 69 (15–84)
WHO classification, n° (%) of the patients  
RA 7 (13)
RCMD 24 (45)
RCMD-RS 11 (20)
RAEB-1 6 (11)
RAEB-2 6 (11)
IPSS-R risk group of the patients  
Very Low 5
Low 17
Intermediate 16
High 10
Very High 3
IPSS risk group of the patients  
Low 15
Intermediate-1 25
Intermediate-2 9
High 2
WPSS of the patients  
Very low 3
Low 12
Intermediate 22
High 12
Very High 2
  1. WHO, World Health Organization; RA, refractory anemia; RCMD, refractory cytopenia with multilineage dysplasia; RAEB, refractory anemia with excess blasts; IPSS International Prognostic Scoring System; WPSS, WHO classification- based prognostic scoring system; ANC, absolute neutrophil count.